Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.03.2024 | Case report

Tecovirimat

Drug resistance

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Mertes H, et al. Tecovirimat Resistance in an Immunocompromised Patient With Mpox and Prolonged Viral Shedding. Annals of Internal Medicine 176: 1141-1143, No. 8, Aug 2023. Available from: URL: 10.7326/L23-0131 Mertes H, et al. Tecovirimat Resistance in an Immunocompromised Patient With Mpox and Prolonged Viral Shedding. Annals of Internal Medicine 176: 1141-1143, No. 8, Aug 2023. Available from: URL: 10.7326/L23-0131
Metadaten
Titel
Tecovirimat
Drug resistance
Publikationsdatum
01.03.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-55361-z

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Mitotane

Case report

Crizotinib

Case report

Azacitidine

Case report

Multiple drugs